The Influence of a Normal Myocardial Perfusion SPECT on Prescription of Preventive Cardiovascular Medications and Patients’ Adherence

ARYEH SHALEV 1,2 Noga Michnovsky 2 Arik Wolak 3 Victor Novack 4 Ronen Toledano 4 Yaakov Henkin 1,2
1Cardiology Department, Soroka University Medical Center, Be'er Sheva
2Faculty of Health Sciences, The Joyce & Irving Goldman Medical School, Ben Gurion University of The Negev, Be'er Sheva, Israel
3Cardiac Imaging Unit, Cardiology Department, Sha'are Zedek Medical Center, Jerusalem
4Clinical Research Center, Soroka University Medical Center, Ben Gurion University of The Negev, Be'er Sheva, Israel

Background: Abnormal SPECT myocardial perfusion imaging (SPECT-MPI) denotes obstructive coronary artery disease (CAD) and is predictive of cardiovascular events. Conversely, a normal scan is associated with a low short-term risk. An abnormal SPECT-MPI has been shown to lead to enhanced medical therapy and patients’ adherence. We hypothesized that a normal SPECT-MPI, in subjects without known CAD, would lead to a decrease in preventive therapy.

Methods: a retrospective cohort study that included all subjects without known CAD, that had their first SPECT-MPI scan at Soroka-Medical-Center between 1997-2008. Baseline characteristics, prescription retrieval of aspirin and a statin from the HMO pharmacy within 1 year from SPECT-MPI, and health status, were retrieved from the central database of Clalit-Health-Services. Medication non-adherence was defined as <50% retrieval. We compared subjects with normal scan (summed stress score - SSS<2) vs. abnormal scan. Parsimonious cox regression model was utilized to assess multiple variables associated with increased risk of myocardial infarction and cardiac mortality within 8 years after SPECT-MPI and with 1-year drug cessation.

Results: 11,642 subjects had a normal SPECT-MPI, and in comparison to subjects with abnormal scan (n=6892) were predominantly female (56.6% vs. 24.7%,p<0.001), at younger age (64.1±11.2 vs. 65.4±10.8,p<0.001) and were less likely to be smokers (13.2% vs. 15.5%, p<0.001). Statin and aspirin use at 1-year period post-scan were both increased in the study group in comparison to the pre-scan period (50.6% vs. 41.5% pre-scan for statin, and 49.6% vs. 41.5% for aspirin, p









Powered by Eventact EMS